Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2025

Nov 13, 2025

29745_dirs_2025-11-13_3565f7b1-2f9c-4f9f-acea-6afe81b146df.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-11-12

Reporting Person: LILLY ENDOWMENT INC (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-11-12 Common Stock S 828 $1001.93 Disposed 93411150 Direct
2025-11-12 Common Stock S 7585 $1003.116 Disposed 93403565 Direct
2025-11-12 Common Stock S 22131 $1004.099 Disposed 93381434 Direct
2025-11-12 Common Stock S 23568 $1004.968 Disposed 93357866 Direct
2025-11-12 Common Stock S 23863 $1006.017 Disposed 93334003 Direct
2025-11-12 Common Stock S 16383 $1007.099 Disposed 93317620 Direct
2025-11-12 Common Stock S 8913 $1007.968 Disposed 93308707 Direct
2025-11-12 Common Stock S 17985 $1009 Disposed 93290722 Direct
2025-11-12 Common Stock S 20000 $1009.987 Disposed 93270722 Direct
2025-11-12 Common Stock S 19892 $1011.177 Disposed 93250830 Direct
2025-11-12 Common Stock S 21559 $1011.961 Disposed 93229271 Direct
2025-11-12 Common Stock S 16749 $1012.942 Disposed 93212522 Direct
2025-11-12 Common Stock S 11638 $1014.169 Disposed 93200884 Direct
2025-11-12 Common Stock S 16274 $1015.158 Disposed 93184610 Direct
2025-11-12 Common Stock S 13415 $1016.005 Disposed 93171195 Direct
2025-11-12 Common Stock S 7188 $1017.156 Disposed 93164007 Direct
2025-11-12 Common Stock S 47073 $1018.022 Disposed 93116934 Direct
2025-11-12 Common Stock S 7833 $1018.829 Disposed 93109101 Direct
2025-11-12 Common Stock S 1281 $1019.919 Disposed 93107820 Direct
2025-11-12 Common Stock S 842 $1021.065 Disposed 93106978 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,001.213 to $1,002.20, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), and (20) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,002.52 to $1,003.51, inclusive.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,003.52 to $1,004.515, inclusive.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,004.53 to $1,005.527, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,005.535 to $1,006.53, inclusive.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,006.54 to $1,007.53, inclusive.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,007.54 to $1,008.52, inclusive.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,008.54 to $1,009.535, inclusive.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,009.54 to $1,010.53, inclusive.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,010.54 to $1,011.53, inclusive.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,011.55 to $1,012.545, inclusive.

F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,012.55 to $1,013.532, inclusive.

F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,013.59 to $1,014.56, inclusive.

F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,014.59 to $1,015.58, inclusive.

F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,015.59 to $1,016.439, inclusive.

F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,016.60 to $1,017.54, inclusive.

F17: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,017.63 to $1,018.62, inclusive.

F18: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,018.65 to $1,019.421, inclusive.

F19: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,019.651 to $1,020.375 inclusive.

F20: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,020.664 to $1,021.661, inclusive.